New York, NY, Oct. 04, 2023 (GLOBE NEWSWIRE) -- BioPlus Acquisition Corp. (“BIOS” or the “Company”) (Nasdaq: BIOS) announced today that (i...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K ...
false 0001856653 0001856653 2023-06-14 2023-06-14 0001856653 us-gaap:CapitalUnitsMember 2023-06-14 2023-06-14 0001856653...
Filed by BioPlus Acquisition Corp. pursuant to Rule 425 under the Securities Act of 1933 and...
Filed by BioPlus Acquisition Corp. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to...
falseQ10001856653--12-31NY 0001856653 2023-01-01 2023-03-31 0001856653 2022-01-01 2022-03-31 0001856653 2023-03-31 0001856653 2022-12-31...
Table of Contents false0001856653 0001856653 2022-01-01 2022-12-31 0001856653 2021-02-11 2021-12-31...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.